Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 7762-7771

  Pope, Jonathan G ^a   Vanderlugt, Carol L ^a   Rahbe, Sandra M ^a   Lipton, Howard L ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEMYELINATION; FEMALE; GLIOSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONONUCLEAR CELL; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031667213     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.7762-7771.1998     Document Type: Article

References (65)

1. Berkower, I., G. K. Buckenmeyer, F. R. Gurd, and J. A. Berzofsky. 1982. A possible immunodominant epitope recognized by murine T lymphocytes immune to different myoglobins. Proc. Natl. Acad. Sci. USA 79:4723-4727.
2. Borrow, P., and A. A. Nash. 1992. Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology 76:133-139.
3. + T lymphocytes in the central nervous system. Clin. Exp. Immunol. 98:313-318.
4. Clatch, R. J., R. W. Melvold, M. C. Dal Canto, S. D. Miller, and H. L. Lipton. 1987. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. J. Neuroimmunol. 15:121-135.
5. Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
6. Cserr, H. F., and P. M. Knopf. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 13:507-512.
7. Dal Canto, M. C. 1982. Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler's virus encephalomyelitis. Infect. Immun. 35:1133-1138.
8. Dal Canto, M. C., and R. L. Barbano. 1985. Immunocytochemical localization of MAG, MBP and P0 protein in acute and relapsing demyelinating lesions of Theiler's virus infection. J. Neuroimmunol. 10:129-140.
9. Dal Canto, M. C., and H. L. Lipton. 1982. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106:20-29.
10. De Simone, R., A. Giampaolo, B. Giometto, P. Gallo, G. Levi, C. Peschle, and F. Aloisi. 1995. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:175-187.
11. Fontana, A., W. Fierz, and H. Wekerle. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273-276.
12. Ford, A. L., A. L. Goodsall, W. F. Hickey, and J. D. Sedgwick. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154:4309-4321.
13. Frei, K., C. Siepl, P. Groscurth, S. Bodmer, C. Schwerdel, and A. Fontana. 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1271-1278.
14. Friedmann, A., G. Frankel, Y. Lorch, and L. Steinman. 1987. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 61:898-903.
15. Gerety, S. J., R. J. Clatch, H. L. Lipton, R. G. Goswami, M. K. Rundell, and S. D. Miller. 1991. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice. J. Immunol. 146:2401-2408.
16. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-929.
17. Graves, M. C., L. Bologa, L. Siegel, and H. Londe. 1986. Theiler's virus in brain cell cultures: lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J. Neurosci. Res. 15:491-501.
18. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994 Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
19. Havenith, C. E. G., D. Askew, and W. S. Walker. 1998. Mouse resident microglia: isolation and characterization of immunoregulatory properties with naive CD4+ and CD8+ T cells. Glia 22:348-359.
20. Hickey, W. F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292.
21. Hickey, W. F., J. P. Osborn, and W. M. Kirby. 1985. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell. Immunol. 91:528-535.
22. Hinrichs, D. J., K. W. Wegmann, and G. N. Dietsch. 1987. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element. J. Exp. Med. 166:1906-1911.
23. Hofman, F. M., R. I. von Hanwehr, C. A. Dinarello, S. B. Mizel, D. Hinten, and J. E. Merrill. 1986. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J. Immunol. 136:3239-3245.
24. Jenkins, M. K. 1995. The ups and downs of costimulation. Immunity 1:443-446.
25. Jordan, F. L., and W. E. Thomas. 1988. Brain macrophages: a question of origin and interrelationship. Brain Res. Rev. 13:165-178.
26. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321-331.
27. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:721-730.
28. Karpus, W. J., J. G. Pope, J. D. Peterson, M. C. Dal Canto, and S. D. Miller. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:947-957.
29. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nahavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
30. Kurtzke, J. F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
31. Lanzavecchia, A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 8:773-793.
32. Lenschow, D. J., G. H. Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90:11054-11058.
33. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
34. Levy, M., C. Aubert, and M. Brahic. 1992. Theiler's virus replication in brain macrophages cultured in vitro. J. Virol. 66:3188-3193.
35. Lipton, H. L., and M. C. Dal Canto. 1976a. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 30:201-207.
36. Lipton, H. L., and M. C. Dal Canto. 1976b. Theiler's virus-induced demyelination: prevention by immunosuppression. Science 192:62-64.
37. Lipton, H. L., and M. C. Dal Canto. 1977. Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect. Immun. 15:903-909.
38. Lipton, H. L., and M. C. Dal Canto. 1979. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect. Immun. 26:369-374.
39. Lipton, H. L., and F. Gonzalez-Scarano. 1978. Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J. Infect. Dis. 137:145-151.
40. Lipton, H. L., and R. Melvold. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1821-1825.
41. Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533.
42. Matsumoto, Y., K. Ohmori, and M. Fujiwara. 1992. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76:209-216.
43. McRae, B. L., M. K. Kennedy, L. J. Tan, M. C. Dal Canto, and S. D. Miller. 1992. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229-240.
44. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med. 182:75-85.
45. Miller, S. D., R. J. Clatch, D. C. Pevear, J. L. Trotter, and H. L. Lipton. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138:3776-3784.
46. Miller, S. D., S. J. Gerety, M. K. Kennedy, J. D. Peterson, J. L. Trotter, V. K. Tuohy, C. Waltenbaugh, M. C. Dal Canto, and H. L. Lipton. 1990. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 26:9-23.
47. Miller, S. D., B. L. McRae, C. L. Vanderlugt, K. M. Nikcevich, J. G. Pope, L. Pope, and W. J. Karpus. 1995. Evolution of the T cell repertoire during the course of experimental autoimmune encephalomyelitis. Immunol. Rev. 144:225-244.
48. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
49. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739-745.
50. Myers, K. J., J. P. Dougherty, and Y. Ron. 1993. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J. Immunol. 151:2252-2260.
51. Nikcevich, K. M., K. B. Gordon, L. Tan, S. D. Hurst, J. F. Kroepfl, M. Gardinier, T. A. Barrett, and S. D. Miller. 1997. Interferon-gamma activated primary murine astrocytes express B7 costimulalory molecules and prime naive antigen-specific T cells. J. Immunol. 158:614-621.
52. Perry, V. H., P. R. Crocker, and S. Gordon. 1992. The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J. Cell Sci. 101:201-207.
53. Perry, V. H., D. A. Hume, and S. Gordon. 1985. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15:313-326.
54. + T cell-mediated pathology. J. Immunol. 156:4050-4058.
55. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-433.
56. Rossi, C. P., M. Delcroix, I. Huitinga, A. McAllister, N. Van Rooijen, E. Claassen, and M. Brahic. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340.
57. Sedgwick, J. D., S. Schwender, H. Imrich, R. Dörries, G. W. Butcher, and V. ter Meulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88:7438-7442.
58. Steiner, C. M., E. J. Rozhon, and H. L. Lipton. 1984. Relationship between host age and persistence of Theiler's virus in the central nervous system of mice. Infect. Immun. 43:432-434.
59. Tan, L. J., K. B. Gordon, J. P. Mueller, L. A. Matis, and S. D. Miller. 1998. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J. Immunol. 160:4271-1279.
60. Traugott, U. 1987. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J. Neuroimmunol. 16:283-302.
61. Traugott, U., and P. Lebon. 1988. Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions. Ann. N.Y. Acad. Sci. 540:309-311.
62. Traugott, U., E. L. Reinherz, and C. S. Raine. 1983. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308-310.
63. Welsh, C. J., P. Tonks, A. A. Nash, and W. F. Blakemore. 1987. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 68:1659-1667.
64. Williams, K., E. Ulvestad, and J. P. Antel. 1994. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:3031-3037.
65. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD80), and interleukin 13 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985-1996.